Son, Kyeong Min
Hong, Jeong Im
Kim, Dong-Hyun
Jang, Dae-Gyu
Crema, Michel D.
Kim, Hyun Ah http://orcid.org/0000-0002-9318-7446
Funding for this research was provided by:
the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C0287)
the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (2017R1A2B2001881)
Hallym University research fund
Article History
Received: 5 March 2020
Accepted: 15 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: The HAS study and KNHANES study were approved by the institutional review board of the Hallym University School of Medicine (IRB approval number: HIRB-2007-001) and by the Korea Centers for Disease Control and Prevention institutional review board in Korea (2010-02CON-21-C, 2011-02CON-06-C and 2012-01EXP-01-2C), respectively. Both study protocols conformed to the ethical guidelines of the 1975 Declaration of Helsinki and written informed consent was obtained from each participant.
: Not applicable.
: The authors declare that they have no competing interests. The OAI is a public-private partnership comprised of five contracts funded by the National Institutes of Health. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc.